Oxycodone

Generic Name
Oxycodone
Brand Names
Endocet, Endodan Reformulated May 2009, Nalocet, Oxaydo, Oxy.IR, Oxycontin, Oxyneo, Percocet, Prolate, Rivacocet, Roxicet, Roxicodone, Roxybond, Targin, Targiniq, Xolox, Xtampza
Drug Type
Small Molecule
Chemical Formula
C18H21NO4
CAS Number
76-42-6
Unique Ingredient Identifier
CD35PMG570
Background

Oxycodone is a semisynthetic opioid analgesic derived from thebaine in Germany in 1917. It is currently indicated as an immediate release product for moderate to severe pain and as an extended release product for chronic moderate to severe pain requiring continuous opioid analgesics for an extended period. The first oxycodone containing product, Percodan, was approved by the FDA on April 12, 1950.

Indication

Oxycodone is indicated for the treatment of moderate to severe pain. There is also an extended release formulation indicated for chronic moderate to severe pain requiring continuous opioid analgesics for an extended period.

Associated Conditions
Severe Acute Pain, Severe Pain, Severe, Chronic Pain, Acute, moderate Pain, Chronic, moderate Pain
Associated Therapies
-

The Effect of Oxycodone to the Placental Circulation at Early Labour

Phase 4
Active, not recruiting
Conditions
Interventions
First Posted Date
2015-10-12
Last Posted Date
2023-03-16
Lead Sponsor
Kuopio University Hospital
Target Recruit Count
22
Registration Number
NCT02573831
Locations
🇫🇮

Kuopio University Hospital, Kuopio, Northern Savo, Finland

Opioid Induced Bowel Dysfunction in Patients Undergoing Spinal Surgery

Phase 4
Completed
Conditions
Interventions
First Posted Date
2015-10-12
Last Posted Date
2015-10-12
Lead Sponsor
Kuopio University Hospital
Target Recruit Count
180
Registration Number
NCT02573922
Locations
🇫🇮

Kuopio University Hospital, Kuopio, Northern Savo, Finland

Opioid Induced Bowel Dysfunction in Patients Undergoing Cesarean Section

First Posted Date
2015-10-08
Last Posted Date
2023-03-16
Lead Sponsor
Kuopio University Hospital
Target Recruit Count
57
Registration Number
NCT02571881
Locations
🇫🇮

Kuopio University Hospital, Kuopio, Northern Savo, Finland

Oxycodone Pharmacokinetics in Preterm Infants

Completed
Conditions
Interventions
First Posted Date
2015-09-30
Last Posted Date
2015-09-30
Lead Sponsor
Kuopio University Hospital
Target Recruit Count
79
Registration Number
NCT02564003

A Study Of The Effectiveness Of Wafermine Alone And In Combination With Opioids In Subjects Undergoing Bunionectomy

Phase 2
Completed
Conditions
Interventions
First Posted Date
2015-09-04
Last Posted Date
2016-02-23
Lead Sponsor
iX Biopharma Ltd.
Target Recruit Count
72
Registration Number
NCT02541396
Locations
🇺🇸

Jean Brown Research, Salt Lake City, Utah, United States

A Study to Investigate the Pharmacodynamic Effect of Single Doses of MT-8554 in Healthy Subjects

First Posted Date
2015-08-31
Last Posted Date
2016-01-06
Lead Sponsor
Mitsubishi Tanabe Pharma Corporation
Target Recruit Count
20
Registration Number
NCT02536209
Locations
🇬🇧

Investigational center, City name, United Kingdom

TAP vs Surgical Infiltration of Local Anesthetic in Laparoscopic and Robotic Hysterectomy

First Posted Date
2015-08-10
Last Posted Date
2019-02-08
Lead Sponsor
University of Minnesota
Target Recruit Count
87
Registration Number
NCT02519023
Locations
🇺🇸

University of Minnesota, Minneapolis, Minnesota, United States

Early Postoperative Administration of Oxycodone +/- Naloxone and Duration of Epidural Analgesia

First Posted Date
2015-08-05
Last Posted Date
2017-03-07
Lead Sponsor
Insel Gruppe AG, University Hospital Bern
Target Recruit Count
90
Registration Number
NCT02516059
Locations
🇨🇭

Dep of Urology Bern University Hospital, Bern, Switzerland

Pain Management After Cardiac Surgery - Opioids or NSAID

First Posted Date
2015-06-24
Last Posted Date
2015-06-24
Lead Sponsor
Aalborg University Hospital
Target Recruit Count
182
Registration Number
NCT02479165
© Copyright 2024. All Rights Reserved by MedPath